Related Experiment Video
Updated: Aug 5, 2026

12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
ETVAX: From Concepts to Demonstrated Clinical Efficacy
1Department of Microbiology and Immunology, Institute of Biomedicine, Gothenburg University, 45030 Gothenburg, Sweden.
Microorganisms
|July 28, 2026
Summary
An oral inactivated vaccine against enterotoxigenic Escherichia coli (ETEC) showed promising safety and efficacy. ETVAX protects children and travelers from ETEC-associated diarrhea, offering hope for disease prevention.
Area of Science:
- Vaccinology
- Microbiology
- Infectious Diseases
Background:
- Enterotoxigenic Escherichia coli (ETEC) is a leading cause of bacterial diarrheal disease worldwide.
- Development of effective vaccines against ETEC remains a critical public health challenge.
Purpose of the Study:
- To review the development and clinical evaluation of ETVAX, an oral inactivated ETEC vaccine.
- To summarize the safety, immunogenicity, and protective efficacy of ETVAX formulations.
Main Methods:
- Preclinical studies in animal models to evaluate vaccine components.
- Phase 1 and Phase 2 clinical trials in diverse populations (adults, children) across different geographical regions.
- Assessment of safety, tolerability, immunogenicity (intestinal immune responses), and protective efficacy against ETEC-associated diarrhea.
Main Results:
- Candidate vaccines were well-tolerated and safe in all trials.
- Robust intestinal immune responses were induced against ETEC antigens.
- The final ETVAX formulation demonstrated significant protection against moderate-to-severe ETEC diarrhea in young children and travelers.
Conclusions:
- ETVAX represents a significant advancement in ETEC vaccine development.
- The vaccine shows potential for protecting both endemic populations and international travelers from ETEC-induced illness.
Related Concept Videos
Vaccinations
Overview
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

